OTCMKTS:BIOGY BioGaia AB (publ) (BIOGY) Stock Price, News & Analysis $12.45 0.00 (0.00%) As of 10/16/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendNews and Trends About BioGaia AB (publ) Stock (OTCMKTS:BIOGY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioGaia AB (publ) alerts:Sign Up Key Stats Today's Range$12.45▼$12.4550-Day Range$12.35▼$12.4552-Week Range$9.64▼$12.45VolumeN/AAverage Volume267 shsMarket CapitalizationN/AP/E Ratio2.96Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioGaia AB (publ) is a Swedish health-care company that develops, markets and sells probiotic products. Its portfolio is based primarily on scientifically documented strains of Limosilactobacillus reuteri, formerly known as Lactobacillus reuteri, and is intended to support digestive and immune health. The company offers probiotic products for infants, children and adults, including oral drops, tablets, chewable products and other formulations. Its brands and product lines include BioGaia Protectis for digestive health, BioGaia Gastrus for gastrointestinal support and BioGaia Prodentis for oral health. Products are sold through pharmacies, health-care channels, retailers and e-commerce outlets, depending on the market. BioGaia was founded in Sweden in 1990 and serves customers internationally through its own operations, distributors and commercial partners. The company also collaborates with researchers and health-care professionals to develop and document applications for its probiotic strains. BioGaia AB is headquartered in Stockholm and its shares are listed on Nasdaq Stockholm; the company’s securities also trade in the United States under the symbol BIOGY.AI Generated. May Contain Errors. Read More Receive BIOGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioGaia AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOGY Stock News HeadlinesBioGaia : Nomination Committee for the 2027 Annual General MeetingOctober 15, 2026 | marketscreener.comMBioGaia AB (publ) (BIOGY) Set to Release Earnings on ThursdayOctober 15, 2026 | americanbankingnews.comTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years. | Porter & Company (Ad)Handelsbanken reiterates buy for Biogaia, sees 17% organic growthOctober 14, 2026 | marketscreener.comMBioGaia : Invitation to media and analyst briefing for BioGaia Q3 2026 reportOctober 9, 2026 | marketscreener.comMSB1 Markets upgrades Biogaia to Buy, more attractive setup nowSeptember 28, 2026 | marketscreener.comMWorldquant no longer a public short seller in BiogaiaSeptember 22, 2026 | marketscreener.comMBioGaia AB ADR BIOGYAugust 26, 2026 | morningstar.comMSee More Headlines BIOGY Stock Analysis - Frequently Asked Questions How have BIOGY shares performed this year? BioGaia AB (publ)'s stock was trading at $11.00 at the beginning of the year. Since then, BIOGY shares have increased by 13.2% and is now trading at $12.45. When did BioGaia AB (publ)'s stock split? Shares of BioGaia AB (publ) split on the morning of Thursday, May 26th 2022.The 2.5-1 split was announced on Thursday, May 26th 2022. The newly created shares were issued to shareholders after the market closes on Thursday, May 26th 2022. An investor that had 100 shares of stock prior to the split would have 250 shares after the split. How do I buy shares of BioGaia AB (publ)? Shares of BIOGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/19/2026Next Earnings (Estimated)10/22/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:BIOGY CIK1572957 Webwww.biogaia.com Phone(685) 552-9300FaxN/AEmployees200Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio2.96 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:BIOGY) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our Partners80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioGaia AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share BioGaia AB (publ) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
